• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏免疫中的胆汁酸及其受体

Bile acids and their receptors in hepatic immunity.

作者信息

Fiorucci Stefano, Marchianò Silvia, Distrutti Eleonora, Biagioli Michele

机构信息

Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

SC di Gastroenterologia ed Epatologia, Azienda Ospedaliera di Perugia, Perugia, Italy.

出版信息

Liver Res. 2025 Jan 28;9(1):1-16. doi: 10.1016/j.livres.2025.01.005. eCollection 2025 Mar.

DOI:10.1016/j.livres.2025.01.005
PMID:40206435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11977286/
Abstract

Similarly to conventional steroids, bile acids function as signaling molecules, acting on a family of membrane and nuclear receptors. The best-characterized bile acid-regulated receptors are the farnesoid X receptor, activated by primary bile acids, and the G-protein-coupled bile acid receptor 1 (also known as Takeda G protein-coupled receptor 5), which is activated by secondary bile acids, such as lithocholic acid (LCA) and deoxycholic acid. Both the farnesoid X receptor and G-protein-coupled bile acid receptor 1 are expressed in cells of innate immunity, monocytes/macrophages, and natural killer cells. Their activation in these cells provides counter-regulatory signals that are inhibitory in nature and attenuate inflammation. In recent years, however, it has been increasingly appreciated that bile acids biotransformations by intestinal microbiota result in the formation of chemically different secondary bile acids that potently regulate adaptive immunity. The 3-oxoLCA and isoalloLCA, two LCA derivatives, bind receptors such as the retinoic acid receptor-related orphan receptor gamma t (RORγt) and the vitamin D receptor (VDR) that are expressed only by lymphoid cells, extending the regulatory role of bile acids to T cells, including T-helper 17 cells and type 3 innate lymphoid cells (ILC3). In this novel conceptual framework, bile acids have emerged as one of the main components of the postbiota, the waste array of chemical mediators generated by the intestinal microbiota. Deciphering the interaction of these mediators with the immune system in the intestine and liver is a novel and fascinating area of bile acid renaissance.

摘要

与传统类固醇类似,胆汁酸作为信号分子发挥作用,作用于一系列膜受体和核受体。研究最为充分的胆汁酸调节受体是法尼醇X受体,它由初级胆汁酸激活;还有G蛋白偶联胆汁酸受体1(也称为武田G蛋白偶联受体5),它由次级胆汁酸激活,如石胆酸(LCA)和脱氧胆酸。法尼醇X受体和G蛋白偶联胆汁酸受体1均在先天免疫细胞、单核细胞/巨噬细胞和自然杀伤细胞中表达。它们在这些细胞中的激活提供了具有抑制性质的反调节信号,并减轻炎症。然而,近年来,人们越来越认识到肠道微生物群对胆汁酸的生物转化会导致形成化学性质不同的次级胆汁酸,这些次级胆汁酸能有效调节适应性免疫。两种LCA衍生物3-氧代LCA和异别alloLCA可结合仅由淋巴细胞表达的受体,如视黄酸受体相关孤儿受体γt(RORγt)和维生素D受体(VDR),从而将胆汁酸的调节作用扩展到T细胞,包括辅助性T细胞17和3型固有淋巴细胞(ILC3)。在这个新的概念框架中,胆汁酸已成为后生生物群的主要成分之一,后生生物群是肠道微生物群产生的化学介质废物阵列。解读这些介质与肠道和肝脏免疫系统之间的相互作用是胆汁酸复兴的一个新颖而迷人的领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6349/11977286/a656486c286f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6349/11977286/778a88eade9d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6349/11977286/089d0e26adb5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6349/11977286/a656486c286f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6349/11977286/778a88eade9d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6349/11977286/089d0e26adb5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6349/11977286/a656486c286f/gr3.jpg

相似文献

1
Bile acids and their receptors in hepatic immunity.肝脏免疫中的胆汁酸及其受体
Liver Res. 2025 Jan 28;9(1):1-16. doi: 10.1016/j.livres.2025.01.005. eCollection 2025 Mar.
2
Bile Acids Activated Receptors Regulate Innate Immunity.胆汁酸激活受体调节先天免疫。
Front Immunol. 2018 Aug 13;9:1853. doi: 10.3389/fimmu.2018.01853. eCollection 2018.
3
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity.从肠道到宿主的信号传导:胆汁酸如何调节肠道和肝脏免疫。
Handb Exp Pharmacol. 2019;256:95-108. doi: 10.1007/164_2019_225.
4
Phenotyping the Chemical Communications of the Intestinal Microbiota and the Host: Secondary Bile Acids as Postbiotics.肠道微生物群与宿主化学通讯的表型分析:次级胆汁酸作为益生元后体。
Cells. 2025 Apr 15;14(8):595. doi: 10.3390/cells14080595.
5
Bile Acids Activated Receptors in Inflammatory Bowel Disease.胆汁酸激活受体在炎症性肠病中的作用。
Cells. 2021 May 21;10(6):1281. doi: 10.3390/cells10061281.
6
Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases.胆汁酸在心脏代谢疾病中协调微生物群稳态和全身免疫代谢。
Acta Pharm Sin B. 2022 May;12(5):2129-2149. doi: 10.1016/j.apsb.2021.12.011. Epub 2021 Dec 22.
7
Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation.胆汁酸激活受体与肠道-肝脏炎症中的微生物组间的串扰。
Trends Mol Med. 2022 Mar;28(3):223-236. doi: 10.1016/j.molmed.2021.12.006. Epub 2022 Jan 21.
8
Bile Acid Signaling in Inflammatory Bowel Diseases.胆汁酸信号在炎症性肠病中的作用。
Dig Dis Sci. 2021 Mar;66(3):674-693. doi: 10.1007/s10620-020-06715-3. Epub 2020 Dec 8.
9
Immunomodulatory functions of FXR.FXR 的免疫调节功能。
Mol Cell Endocrinol. 2022 Jul 1;551:111650. doi: 10.1016/j.mce.2022.111650. Epub 2022 Apr 25.
10
Bile acid metabolites enhance expression of cathelicidin antimicrobial peptide in airway epithelium through activation of the TGR5-ERK1/2 pathway.胆汁酸代谢物通过激活 TGR5-ERK1/2 通路增强气道上皮细胞中抗菌肽 cathelicidin 的表达。
Sci Rep. 2024 Mar 21;14(1):6750. doi: 10.1038/s41598-024-57251-3.

本文引用的文献

1
Role of immune cell interactions in alcohol-associated liver diseases.免疫细胞相互作用在酒精性肝病中的作用。
Liver Res. 2024 Jun 10;8(2):72-82. doi: 10.1016/j.livres.2024.06.002. eCollection 2024 Jun.
2
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease.胆汁酸激活受体:整合非酒精性脂肪性肝病中的免疫与代谢调节
Liver Res. 2021 Sep 2;5(3):119-141. doi: 10.1016/j.livres.2021.08.003. eCollection 2021 Sep.
3
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism.
微生物衍生的胆汁酸通过激活GPBAR1和反向激活RORγt来逆转炎症性肠病中的炎症。
Biomed Pharmacother. 2024 Dec;181:117731. doi: 10.1016/j.biopha.2024.117731. Epub 2024 Dec 9.
4
Current Landscape and Evolving Therapies for Primary Biliary Cholangitis.原发性胆汁性胆管炎的现状和不断发展的治疗方法。
Cells. 2024 Sep 19;13(18):1580. doi: 10.3390/cells13181580.
5
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases.开发双重 GPBAR1 激动剂和 RORγt 反向激动剂用于治疗炎症性肠病。
Pharmacol Res. 2024 Oct;208:107403. doi: 10.1016/j.phrs.2024.107403. Epub 2024 Sep 10.
6
Immunology of bile acids regulated receptors.胆汁酸调控受体的免疫学
Prog Lipid Res. 2024 Jul;95:101291. doi: 10.1016/j.plipres.2024.101291. Epub 2024 Aug 8.
7
The gut microbiota-bile acid axis in cholestatic liver disease.肠肝菌-胆汁酸轴在胆汁淤积性肝病中的作用。
Mol Med. 2024 Jul 19;30(1):104. doi: 10.1186/s10020-024-00830-x.
8
Advances in biomedical applications of vitamin D for VDR targeted management of obesity and cancer.维生素 D 在肥胖症和癌症的 VDR 靶向治疗中的生物医学应用进展。
Biomed Pharmacother. 2024 Aug;177:117001. doi: 10.1016/j.biopha.2024.117001. Epub 2024 Jun 26.
9
IL-17 signaling in primary sclerosing cholangitis patient-derived organoids.原发性硬化性胆管炎患者来源类器官中的 IL-17 信号转导。
Hepatol Commun. 2024 Jun 3;8(6). doi: 10.1097/HC9.0000000000000454. eCollection 2024 Jun 1.
10
Metabolic reprogramming in liver fibrosis.肝纤维化中的代谢重编程。
Cell Metab. 2024 Jul 2;36(7):1439-1455. doi: 10.1016/j.cmet.2024.05.003. Epub 2024 May 31.